Navigation Links
Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
Date:2/13/2008

between $1.64 and $1.72, based on approximately 56 million

fully diluted shares outstanding for the year and a tax rate of 35%.

Recent Events

-- PROCLEIX ULTRIO Post-Marketing Study. Gen-Probe believes the Company

has met its goal of identifying a second case of hepatitis B "yield"

in the post-marketing study for the PROCLEIX ULTRIO assay. Yield is

defined as an HBV-infected blood donation that was intercepted by the

PROCLEIX ULTRIO assay, but that was initially negative based on

traditional serology tests. To date, participating blood banks have

screened approximately 500,000 blood donations in the study. The FDA

has approved the PROCLEIX ULTRIO assay to screen donated blood for

HIV-1 and hepatitis C virus (HCV), but not to screen for HBV, as the

initial clinical studies were not designed to, and did not,

demonstrate HBV yield. Within a month, Gen-Probe intends to submit a

supplemental Biologics License Application (BLA) to the US Food and

Drug Administration in hopes of gaining a donor screening claim for

HBV.

-- Carl Hull Named President and COO. On February 11, Gen-Probe

announced that Carl Hull was named the Company's president and chief

operating officer, effective March 1, 2008. Mr. Hull joined Gen-Probe

in February of 2007 as executive vice president and chief operating

officer. He oversees the Company's major operating functions,

including research and development, manufacturing, and sales and

marketing.

-- New Operations Executive. On November 19, Gen-Probe announced that

Jorgine Ellerbrock joined the Company as senior vice president,

operations. She joined the Company from Invitrogen Corporation, where

she had been vice president, operations, since 2004, most recently for

the Molecul
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Carl Hull Named President and Chief Operating Officer of Gen-Probe
2. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
3. Gen-Probe to Webcast Three Upcoming Presentations
4. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
5. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
6. Imagenetix Inc. Reports Third Fiscal Quarter Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 AudioNotch is ... new therapy for the treatment of tinnitus. Patients listen ... frequency, and over a period of weeks to months, their ... Therapy in two forms: Notched Music and Notched White Noise. ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider of strategic ... business, and media events in the United States ... associate Virginia Cox , JD, is returning to the firm,s ... Cox re-joins 3D after more than two years of service ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, today ... In this role, Michelle will work with current and potential ... development of iLab products. Her main goal will be to ... scientific community by offering the most advanced, user-friendly, and high-impact ...
(Date:1/14/2014)... January 13, 2014 Bob Hainsey, a ... than 20 years in the industry, has joined ... Hainsey will serve as the society’s Science and Technology ... join SPIE as our Technology Strategist, further strengthening the ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... BASINGSTOKE, England and PHILADELPHIA, Pennysylvania, March 3, Shire ... biopharmaceutical company, notes that Renovo Group plc, (LSE:,RNVO) ... latest Phase 2,studies of JUVISTA(R) (human recombinant TGFbeta3) ... (RN1001-319-1010)., Renovo’s press release can be found ...
... and MONTREAL, March 3 /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. ... company,focused on endocrine therapy and oncology, and Paladin ... company, announced today,that they have entered into a ... rights related to the manufacture, production, distribution,marketing, sale ...
... Feb. 29 Wyeth Pharmaceuticals,a division of Wyeth ... U.S. Food and,Drug Administration (FDA) has approved PRISTIQ(TM) ... treat adult patients with major depressive disorder (MDD). ... in the second,quarter of 2008., "We are ...
Cached Biology Technology:Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 2Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3) 3AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights 2AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights 3FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 2FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 3FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 4FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 5FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 6FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 7FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 8FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder 9
(Date:4/20/2014)... gene expression analysis growing in importance for both ... Mellon University and the University of Maryland have ... up estimates of gene activity from RNA sequencing ... after the famously speedy fish, estimates of gene ... completed in a few minutes, with accuracy that ...
(Date:4/20/2014)... newborn baby a gift of germsgerms that help ... used to fend off infection, may paradoxically interrupt ... babies more susceptible to dangerous pathogens. , ... The Children,s Hospital of Philadelphia (CHOP) sheds light ... microbes play a crucial role in fostering the ...
(Date:4/20/2014)... crop residue to make ethanol and other biofuels reduces ... gasoline, according to a study published today in the ... by a University of Nebraska-Lincoln team of researchers cast ... meet federal mandates to ramp up ethanol production and ... stalks, leaves and cobs in cornfields after harvest -- ...
Breaking Biology News(10 mins):Computational method dramatically speeds up estimates of gene expression 2Study of gut microbes, antibiotics: Clues to improving immunity in premature infants 2Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3
... called CD14 binds to substances liberated from the bacteria ... published in the Journal of Biological Chemistry, scientists in ... and showed how it is perfectly suited to bind ... the "Paper of the Week" in the March 25 ...
... number of genes we have in our genome—more than ... genetic truth has often been obscured. The expression of ... host of non-coding sequences, which bind transcription factors and ... coding sequences, whose signatures are easy to spot, the ...
... and MYC cooperate with each other to promote pediatric ... finding, from investigators at St. Jude Children's Research Hospital, ... Biology (MCB). , B-cell lymphoma is a cancer in ... crowd out other blood cells. The St. Jude researchers ...
Cached Biology News:Scientists solve structure of key protein in innate immune response 2Unexpressed But Indispensable -- The DNA Sequences That Control Development 2TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 2TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas 3
...
Contains L-glutamine...
...
... ZMD.358. Immunogen: Synthetic peptide ... of human mouse and rat ... human and mouse LRP5 proteins. ... controls: mouse LRP5-pSEC-tag-transfected 293T cells ...
Biology Products: